StimAire
Tucson, US · Founded 2018 · Delaware corporation · 2 known investors
StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.
Founders & leadership
StimAire was founded in 2018 by Tarek Makansi.
TM
Tarek MakansiinFounder
Investors · 2
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2019
▶$1.6MraisedNov 2019 · 16 investors · Other Health CareRule 506(b)
▶$1.6MraisedNov 2019 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tarek MakansiExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $1.6M
- Minimum investment
- $3K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Inspire Medical6 shared keywordsInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Lunair Medical5 shared keywordsLunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.
Stimdia Medical4 shared keywordsStimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
Somnairsleep4 shared keywordsSomnair develops a non-invasive neurostimulation device for treating obstructive sleep apnea that can be used at home. The device targets the millions of sleep apnea patients who fail or reject existing invasive treatments like CPAP therapy.
Companies competing with StimAire for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does StimAire do?
- StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.
- Who founded StimAire?
- StimAire was founded by Tarek Makansi in 2018.
- Who are StimAire's investors?
- StimAire's investors include University Associates Venture Capital, UAVenture Capital.
- How much funding has StimAire raised?
- StimAire has disclosed $1.6M raised across 1 round.
- Where is StimAire headquartered?
- StimAire is headquartered in Tucson, US.